In fact, while the E-CAD expression was decreasing at the advanced stages (starting from the EMT and marked by cancer invasion and migration), the N-CAD expression was increasing; and both markers were prognosticators of poor survival outcomes (32). This evidence concerns the gene CDH1 and cancer.